Schulman KL, Kohles J. Economic burden of metastatic bone disease in the US. Cancer. 2007;109(11):2334–42. https://doi.org/10.1002/cncr.22678.

Article  PubMed  Google Scholar 

Shiloh R, Krishnan M. Radiation for treatment of painful bone metastases. Hematol Oncol Clin North Am. 2018;32(3):459–68. https://doi.org/10.1016/j.hoc.2018.01.008.

Article  PubMed  Google Scholar 

D’Oronzo S, Coleman R, Brown J, Silvestris F. Metastatic bone disease: pathogenesis and therapeutic options. J Bone Oncol. 2018;15:004. https://doi.org/10.1016/j.jbo.2018.10.004.

Article  PubMed  PubMed Central  Google Scholar 

Goyal G, Kommalapati A, Bartley AC, Gunderson TM, Adjei AA, Go RS. Association between hospital volume and mortality of patients with metastatic non-small cell lung cancer. Lung Cancer Amst Neth. 2018;122:214–9. https://doi.org/10.1016/j.lungcan.2018.06.025.

Article  Google Scholar 

Zhu P, Du XL, Zhu JJ, Esquenazi Y. Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the national cancer database. J Neurosurg. 2019;132(2):491–502. https://doi.org/10.3171/2018.10.JNS182247.

Article  PubMed  Google Scholar 

Ho V, Heslin MJ, Yun H, Howard L. Trends in hospital and surgeon volume and operative mortality for cancer surgery. Ann Surg Oncol. 2006;13(6):851–8. https://doi.org/10.1245/ASO.2006.07.021.

Article  PubMed  Google Scholar 

Hamidi M, Hanna K, Omesiete P, et al. Does it matter where you get your surgery for colorectal cancer? Int J Colorectal Dis. 2019;34(12):2121–7. https://doi.org/10.1007/s00384-019-03436-6.

Article  PubMed  Google Scholar 

Pezzin LE, Laud P, Yen TWF, Neuner J, Nattinger AB. Reexamining the relationship of breast cancer hospital and surgical volume to mortality: an instrumental variable analysis. Med Care. 2015;53(12):1033–9. https://doi.org/10.1097/MLR.0000000000000439.

Article  PubMed  PubMed Central  Google Scholar 

Wang S, Lai S, von Itzstein MS, et al. Type and case volume of health care facility influences survival and surgery selection in cases with early-stage non-small cell lung cancer. Cancer. 2019;125(23):4252–9. https://doi.org/10.1002/cncr.32377.

Article  PubMed  Google Scholar 

Cole AP, Sun M, Lipsitz SR, Sood A, Kibel AS, Trinh QD. Reassessing the value of high-volume cancer care in the era of precision medicine. Cancer. 2018;124(7):1319–21. https://doi.org/10.1002/cncr.31254.

Article  PubMed  Google Scholar 

Williams SB, Ray-Zack MD, Hudgins HK, et al. Impact of Centralizing care for genitourinary malignancies to high-volume providers: a systematic review. Eur Urol Oncol. 2019;2(3):265–73. https://doi.org/10.1016/j.euo.2018.10.006.

Article  PubMed  Google Scholar 

Freeman AT, Kuo M, Zhou L, et al. Influence of treating facility, provider volume, and patient-sharing on survival of patients with multiple myeloma. J Natl Compr Cancer Netw JNCCN. 2019;17(9):1100–8. https://doi.org/10.6004/jnccn.2019.7298.

Article  PubMed  Google Scholar 

Cowan RA, O’Cearbhaill RE, Gardner GJ, et al. Is it time to centralize ovarian cancer care in the United States? Ann Surg Oncol. 2016;23(3):989–93. https://doi.org/10.1245/s10434-015-4938-9.

Article  PubMed  Google Scholar 

Kommalapati A, Tella SH, Appiah AK, Smith L, Ganti AK. Association between treatment facility volume, therapy types, and overall survival in patients with stage IIIA non-small cell lung cancer. J Natl Compr Cancer Netw JNCCN. 2019;17(3):229–36. https://doi.org/10.6004/jnccn.2018.7086.

Article  CAS  PubMed  Google Scholar 

Sharma A, Schwartz SM, Méndez E. Hospital volume is associated with survival but not multimodality therapy in Medicare patients with advanced head and neck cancer. Cancer. 2013;119(10):1845–52. https://doi.org/10.1002/cncr.27976.

Article  PubMed  Google Scholar 

Huo J, Lairson DR, Du XL, et al. Hospital case volume is associated with improved survival for patients with metastatic melanoma. Am J Clin Oncol. 2016;39(5):491–6. https://doi.org/10.1097/COC.0000000000000074.

Article  PubMed  PubMed Central  Google Scholar 

Birkmeyer JD, Sun Y, Wong SL, Stukel TA. Hospital volume and late survival after cancer surgery. Ann Surg. 2007;245(5):777–83. https://doi.org/10.1097/01.sla.0000252402.33814.dd.

Article  PubMed  PubMed Central  Google Scholar 

Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280(20):1747–51. https://doi.org/10.1001/jama.280.20.1747.

Article  CAS  PubMed  Google Scholar 

Abarca T, Gao Y, Monga V, Tanas MR, Milhem MM, Miller BJ. Improved survival for extremity soft tissue sarcoma treated in high-volume facilities. J Surg Oncol. 2018;117(7):1479–86. https://doi.org/10.1002/jso.25052.

Article  PubMed  PubMed Central  Google Scholar 

Schrag D, Cramer LD, Bach PB, Cohen AM, Warren JL, Begg CB. Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA. 2000;284(23):3028–35. https://doi.org/10.1001/jama.284.23.3028.

Article  CAS  PubMed  Google Scholar 

Tucker TC, Charlton ME, Schroeder MC, et al. Improving the quality of cancer care in community hospitals. Ann Surg Oncol. 2021;28(2):632–8. https://doi.org/10.1245/s10434-020-08867-y.

Article  PubMed  Google Scholar 

Herbach EL, McDowell BD, Chrischilles EA, Miller BJ. The Influence of hospital characteristics on patient survival in surgically managed metastatic disease of bone: an analysis of the SEER-medicare linked database. Am J Clin Oncol. 2022;45(8):344–3511. https://doi.org/10.1097/COC.0000000000000929.

Article  PubMed  Google Scholar 

Enewold L, Parsons H, Zhao L, et al. Updated overview of the SEER-medicare data: enhanced content and applications. JNCI Monogr. 2020;2020(55):3–13. https://doi.org/10.1093/jncimonographs/lgz029.

Article  Google Scholar 

Surveillance, Epidemiology, and End Results (SEER) Program. SEER Program & Data - SEER-Medicare. Published online 2021. Accessed October 26, 2021. https://healthcaredelivery.cancer.gov/seermedicare/aboutdata/program.html

Surveillance, Epidemiology, and End Results (SEER) Program. U.S. Mortality Data - SEER Datasets. Published online 2021. Accessed October 26, 2021. https://seer.cancer.gov/mortality/

Surveillance, Epidemiology, and End Results (SEER) Program. Medicare Claims Files - SEER-Medicare. Accessed October 26, 2021. https://healthcaredelivery.cancer.gov/seermedicare/medicare/claims.html#partd

Surveillance, Epidemiology, and End Results (SEER) Program. SEER-Medicare Provider Files. Accessed October 26, 2021. https://healthcaredelivery.cancer.gov/seermedicare/aboutdata/provider.html

Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258–67. https://doi.org/10.1016/s0895-4356(00)00256-0.

Article  CAS  PubMed  Google Scholar 

Goldvaser H, Amir E. Role of bisphosphonates in breast cancer therapy. Curr Treat Options Oncol. 2019;20(4):26. https://doi.org/10.1007/s11864-019-0623-8.

Article  PubMed  Google Scholar 

Mhaskar R, Kumar A, Miladinovic B, Djulbegovic B. Bisphosphonates in multiple myeloma: an updated network meta-analysis. Cochrane Database Syst Rev. 2017. https://doi.org/10.1002/14651858.CD003188.pub4.

Article  PubMed  PubMed Central  Google Scholar 

Musculoskeletal Tumor Society (MSTS), American Society for Radiation Oncology (ASTRO), American Society of Clinical Oncology (ASCO). THE TREATMENT OF METASTATIC CARCINOMA AND MYELOMA OF THE FEMUR: CLINICAL PRACTICE GUIDELINE. Published online 2020. Accessed April 4, 2022. http://msts.org/view/download.php/education/mbd-cpg-amended

Schrag D, Bach PB, Dahlman C, Warren JL. Identifying and measuring hospital characteristics using the seer-medicare data and other claims-based sources. Med Care. 2002;40(8):IV96.

Google Scholar 

Onukwugha E, Mullins CD, Yong C, et al. Bone metastasis (BM) based on SEER registry versus Medicare claims among metastatic prostate cancer (PCa) patients (pts) in SEER-Medicare. J Clin Oncol. 2012;30(suppl 15): e15148.

Article  Google Scholar